Event Recap: How Federal Policies Impact Innovation and Costs of Pharmaceutical Therapies
The Bipartisan Policy Center is hosting three educational forums to inform the national conversation on affordable medicines. The purpose of these forums is to seek an understanding of how private sector decisions and public sector policies impact the prices of drugs and their costs to the health care system. They will highlight what is known about the present system and explore the full range of viewpoints on this issue. BPC hopes each convening will explore how best to support medical innovation while ensuring access and affordability for patients.
The second forum addressed how existing federal statutes and regulations impact pharmaceutical innovation, market competition, and costs.
Join the discussion on Twitter: @BPC_Bipartisan #BPClive
Keynote remarks by:
Gerard Anderson, PhD
Professor of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health
View presentation slides
Panel discussion with:
Scott Gottlieb, M.D.
Resident Scholar, American Enterprise Institute
Former Deputy Commissioner, U.S. Food and Drug Administration
Deputy Chief of Staff, Centers for Medicare & Medicaid Services
Senior Fellow and Director of Health Policy, Manhattan Institute
Executive Director, National Association of Medicaid Directors
Strategic Advisor, Baker Donelson